Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
13,550
+20 (0.15%)
At close: Oct 31, 2025
KRX:019170 Revenue
Shinpoong Pharmaceutical Co.,Ltd had revenue of 58.62B KRW in the quarter ending June 30, 2025, with 4.63% growth. This brings the company's revenue in the last twelve months to 225.09B, up 7.81% year-over-year. In the year 2024, Shinpoong Pharmaceutical Co.,Ltd had annual revenue of 221.09B with 10.42% growth.
Revenue (ttm)
225.09B
Revenue Growth
+7.81%
P/S Ratio
3.33
Revenue / Employee
278.23M
Employees
809
Market Cap
749.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 221.09B | 20.87B | 10.42% |
| Dec 31, 2023 | 200.23B | -9.06B | -4.33% |
| Dec 31, 2022 | 209.29B | 20.05B | 10.60% |
| Dec 31, 2021 | 189.24B | -8.51B | -4.31% |
| Dec 31, 2020 | 197.75B | 8.03B | 4.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.03T |
| Celltrion | 3.75T |
| Yuhan | 2.17T |
| SK Biopharmaceuticals | 620.28B |
| PharmaResearch | 449.81B |
| Sam Chun Dang Pharm. | 215.10B |
| ALTEOGEN | 158.06B |
| LigaChem Biosciences | 148.28B |